RxDoctor Payments Data

Jonathan Epstein

Internal Medicine · Philadelphia, PANPI 1689601585

Payments from drug & device makers

What this record shows

This record is dominated by other: $13,127,854 of the $13,140,160 with a category attached, or 99.9%. AbbVie accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $13,127,854, more than ten times the $7,339 reported in 2022. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,140,160in general payments, 2019–2025

Across 5 payments — averaging $2,628,032 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13.1M
  • Astrazeneca UK Limited$5K
  • AstraZeneca$5K
  • Regeneron$3K

What the payments were for

  • Consulting fees$12,3060%
  • Other$13,127,854100%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1$13,127,854
Astrazeneca UK Limited1$4,967
AstraZeneca2$4,833
Regeneron1$2,506

How this compares

$13,140,160 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania

Other internal medicine in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →